NCT04913376

Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy

Effectiveness of Hilotherapy for the Prevention of Oxaliplatin-induced Peripheral Neuropathy and Pain in the Treatment of Gastrointestinal Tumors: A Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Universitaire Ziekenhuizen KU Leuven · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Effectiveness of hilotherapy for the prevention of oxaliplatin-induced peripheral neuropathy and pain in the treatment of gastrointestinal tumors: A randomized controlled trial.

Detailed description

This study investigates whether constant cooling of the hands and feet using Hilotherm ChemoCare devices reduces the incidence of (severe) oxaliplatin-induced peripheral neuropathy and pain compared to standard care (i.e. no hand and foot cooling) in patients with gastrointestinal tumors.

Conditions

• Quality of Life
• Chemotherapy-induced Peripheral Neuropathy

Interventions

Type	Name	Description
DEVICE	Hilotherapy	Constant cooling device for hands and feet.

Timeline

• Start date: 2021-05-17
• Primary completion: 2022-10-25
• Completion: 2022-10-25
• First posted: 2021-06-04
• Last updated: 2024-07-03

Locations

1 site across 1 country: Belgium